The Cell Therapy Market achieves an impressive13.3% CAGR, soaring to a staggering US$ 19.6 billion by 2030. Advancements in cell culturing, increased R&D investments, and rising awareness drive this exponential growth. With groundbreaking treatments for various medical conditions, including cancer and neurodegenerative disorders, cell therapy is reshaping healthcare, promising a brighter future for patients worldwide.
The report "Cell Therapy Market, By Clinical-use (Therapeutic Area (Malignancies, Muscoskeletal Therapies, Autoimmune Disorders, Dermatology, and Others), Cell Type (Stem Cell Therapies, BM, Blood, & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, and Others), Non-stem Cell Therapies, and Research-use), By Type (Autologous Therapies and Allogenic Therapies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029’’
Sample link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3712
Key Highlights:
• In December 2020, Bayer recently announced the launch of a cell and gene therapy platform (C>) within its pharmaceutical division. The platform will further consolidate its emerging leadership in the cell and gene therapy field and transform its overall business, the company said.
• In July 2021, Ashfield, part of UDG Healthcare, has launched EmerGENE, a global end-to-end cell and gene therapy network approach designed to support small and midsize biotechs with the commercialization of their discoveries. EmerGENE has been built by a multidisciplinary team that delivers expert-led guidance and services to biotechs throughout their entire clinical to commercial journey.
• In July 2021, Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the launch of its next-generation cell line development technology, GPEx Lightning. Leveraging Catalent’s proven GPEx expression platform in a glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line system, GPEx Lightning combines innovative technologies, including a novel gene insertion technology, to further shorten drug substance development by up to three months compared to previous timelines.
Analyst view:
The analyst view on the global cell therapy market is highly optimistic, given its impressive 13.1% CAGR and a substantial value of US$ 19.6 billion. This growth is a testament to the increasing acceptance and adoption of cell-based treatments across the medical community. As cell therapy proves its potential in treating diverse medical conditions, including cancer, neurodegenerative disorders, and cardiovascular diseases, it is revolutionizing the landscape of modern healthcare. Advancements in cell culturing techniques and ongoing research efforts are driving the development of innovative therapies, elevating the market's potential further. The support of governments and regulatory bodies through favorable policies and increased funding has created a conducive environment for cell therapy's growth. The collaborative efforts of pharmaceutical companies, biotech firms, and research organizations have also played a pivotal role in propelling the market forward.
Competitive Landscape:
The key players operating in the global Cell Therapy market include JCR Pharmaceuticals Co. Ltd., Kolon TissueGene, Inc., MEDIPOST, Osiris Therapeutics, Inc., Stemedica Cell Technologies, Inc., Cells for Cells, NuVasive, Inc., Anterogen.Co., Ltd., Fibrocell Science, Inc., Vericel Corporation, and PHARMICELL Co., Ltd.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.